References
- Aalen, O. O., Cook, R. J., and Røysland, K. (2015), “Does Cox Analysis of a Randomized Survival Study Yield a Causal Treatment Effect?,” Lifetime Data Analysis, 21, 579–593. DOI: 10.1007/s10985-015-9335-y.
- Ding, P., and Lu, J. (2017), “Principal Stratification Using Principal Scores,” Journal of the Royal Statistical Society, Series B, 79, 757–777. DOI: 10.1111/rssb.12191.
- Feller, A., Mealli, F., and Miratrix, L. (2017), “Principal Score Methods: Assumptions, Extensions, and Practical Considerations,” Journal of Educational and Behavioral Statistics, 42, 726–758. DOI: 10.3102/1076998617719726.
- Frangakis, C. E., and Rubin, D. B. (2002), “Principal Stratification in Causal Inference,” Biometrics, 58, 21–29. DOI: 10.1111/j.0006-341X.2002.00021.x.
- Hansson, G. K. (2005), “Inflammation, Atherosclerosis and Coronary Artery Disease,” New England Journal of Medicine, 352, 1685–1695. DOI: 10.1056/NEJMra043430.
- Hernán, M. A., and Robins, J. M. (2018), Causal Inference, Boca Raton, FL: Chapman and Hall/CRC.
- ICH (2017), “E9(R1) Statistical Principles for Clinical Trials: Estimands and Sensitivity Analysis in Clinical Trials (Draft),” available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM582738.pdf.
- Imbens, G. W., and Rubin, D. B. (2015), Causal Inference in Statistics, Social, and Biomedical Sciences, New York: Cambridge University Press.
- Mao, H., Li, L., Yang, W., and Shen, Y. (2018), “On the Propensity Score Weighting Analysis With Survival Outcome: Estimands, Estimation, and Inference,” Statistics in Medicine, 37, 3745–3763. DOI: 10.1002/sim.7839.
- Pearl, J. (2009), “Causal Inference in Statistics: An Overview,” Statistics Surveys, 3, 96–146. DOI: 10.1214/09-SS057.
- Richardson, T. S., and Robins, J. M. (2013), “Single World Intervention Graphs (SWIGs): A Unification of the Counterfactual and Graphical Approaches to Causality,” Technical Report, Center for the Statistics and the Social Sciences, University of Washington Series, Working Paper.
- Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., Kastelein, J., Cornel, J., and for the CANTOS Trial Group (2017), “Antiinflammatory Therapy With Canakinumab for Atherosclerotic Disease,” New England Journal of Medicine, 377, 1119–1131. DOI: 10.1056/NEJMoa1707914.
- Royston, P., and Parmar, M. G. (2011), “The Use of Restricted Mean Survival Time to Estimate the Treatment Effect in Randomized Clinical Trials When the Proportional Hazards Assumption Is in Doubt,” Statistics in Medicine, 30, 2409–2421. DOI: 10.1002/sim.4274.
- Rubin, D. (1991), “Comment on Dose Response Estimands, by B. Efron and D. Feldman,” Journal of the American Statistical Association, 86, 22–24. DOI: 10.1080/01621459.1991.10474999.
- VanderWeele, T. (2009), “Concerning the Consistency Assumption in Causal Inference,” Epidemiology, 20, 880–883. DOI: 10.1097/EDE.0b013e3181bd5638.
- VanderWeele, T. (2011), “Controlled Direct and Mediated Effects: Definition, Identification and Bounds,” Scandinavian Journal of Statistics, 38, 551–563. DOI: 10.1111/j.1467-9469.2010.00722.x.
- VanderWeele, T., and Hernán, M. A. (2013), “Causal Inference Under Multiple Versions of Treatment,” Journal of Causal Inference, 1, 1–20. DOI: 10.1515/jci-2012-0002.